|
Browse online courses created through SITC's collaborative partnerships.
|
| Access Course
This article is for people who have advanced kidney cancer and their caregivers, or anyone who wants to learn more about advanced kidney cancer. The goal of this activity is to help people engage in shared decision-making with their doctor about treatment.
In this course, you will learn about:
- What advanced kidney cancer is
- Making a treatment plan with your doctor
- Treatment options for advanced kidney cancer
- Possible side effects of treatment
- Questions to ask your doctor
Available beginning: February 24, 2022
Approximate Time to Complete: 30 minutes
Developed through a partnership between SITC and Medscape.
| | Original Course Date: February 24, 2022
| MORE INFO |
| Access Course
Experts discuss the evolving role of checkpoint inhibition in patients with advanced bladder cancer.
This activity is intended for oncologists, urologists, and other healthcare professionals who treat patients with bladder cancer.
The goal of this activity is to discuss the role of immunotherapy, including how to determine eligibility and how to manage immune-related adverse events (irAEs), in the treatment of advanced bladder cancer.
Approximate Time to Complete: 30 minutes
Credit Available: Apr. 30, 2019- Apr. 30, 2020
Developed through a partnership between SITC and Medscape.
| | Original Course Date: April 30, 2019
| Approved Credit: ABIM: 0.50 hours ABIM MOC Part 2 CreditsACCME (MD/DO): 0.50 hours AMA PRA Category 1 Credit(s)™
| MORE INFO |
| Access Course
Nursing experts discuss the emergence of immunotherapy in GI cancers, focusing on the role of biomarkers and the management of irAEs.
This activity is intended for nurses and other healthcare professionals who manage patients with gastrointestinal cancers.
The goal of this activity is to discuss the emerging role of immunotherapy using immune checkpoint inhibitors in patients with gastrointestinal cancers.
Approximate Time to Complete: 30 minutes
Credit Available: Apr. 30, 2019 - Apr. 30, 2020
Developed through a partnership between SITC and Medscape.
| | Original Course Date: April 30, 2019
| Approved Credit: ANCC: 0.50 hours Contact Hour
| MORE INFO |
| Access Course
This article is for people who have advanced bladder cancer or anyone who wants to learn more about advanced bladder cancer. The goal of this patient education activity is to make patients more aware of available treatment options for advanced bladder cancer.
You will learn about:
- What chemotherapy is and how it is used to treat advanced bladder cancer
- What checkpoint inhibitors are and how they are used to treat advanced bladder cancer
- The potential side effects of chemotherapy and checkpoint inhibitors
- Why the side effects from chemotherapy and checkpoint inhibitors are different
- Questions to ask your doctor
Available beginning: April 26, 2019
Approximate Time to Complete: 30 minutes
Developed through a partnership between SITC and Medscape.
| | Original Course Date: April 26, 2019
| MORE INFO |
| Access Course
Explore the latest in melanoma care through 2 cases, one in the adjuvant setting and one in the metastatic setting.
This activity is intended for oncologists, dermatologists, pathologists, nurses, pharmacists, and other healthcare professionals who manage patients with melanoma.
Credit Available: Feb. 25, 2019 - Feb. 25, 2020
Approximate Time to Complete: 75 minutes
Developed through a partnership between SITC and Medscape.
| | Original Course Date: February 25, 2019
| MORE INFO |
|
|